Berns Paul L's Form 4 filing
Aspen Neuroscience, Inc.ASPE · filed Nov 2, 2026
- Accession no.
- 0001193125-26-444141
- Filed
- Nov 2, 2026, 9:46 PM ET
- Trade date
- Nov 2, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $18.0M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Berns Paul LCIK 0001202769 | 10% Owner |
| ARCH Venture Fund XIV, L.P.CIK 0002138046 | 10% Owner |
| ARCH Venture Partners XIV, L.P.CIK 0002147717 | 10% Owner |
| ARCH Venture Partners XIV, LLCCIK 0002148927 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Common Stock | PPurchaseAcquired | +1,200,000 | $15.00 | +$18,000,000 | 1,200,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
This Form 4 is one of two reports being filed jointly by ARCH Venture Fund X, L.P., ARCH Venture Partners X, L.P., ARCH Venture Fund X Overage, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Partners X, LLC, Robert Nelsen, Steven Gillis, Keith Crandell, and Kristina Burow, AVF XIV, AVP XIV LP, AVP XIV LLC, and Paul Berns (collectively, the "Reporting Persons").